Last update 08 May 2025

HH-006

Overview

Basic Info

Drug Type
Antibody
Synonyms
Target
HBV pre-S1
Action
inhibitors
Mechanism
HBV pre-S1 inhibitors(HBV pre-S1 inhibitors)
Therapeutic Areas
Infectious DiseasesDigestive System DisordersOther Diseases
Active Indication
Hepatitis B, ChronicHepatitis D
Inactive Indication-
Originator Organization
Huahui Health Ltd.Huahui Health Ltd.
Active Organization
Huahui Health Ltd.Huahui Health Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with HH-006
CTR20244743
/ RecruitingPhase 1
评估HH-006注射液在未经治疗慢性乙型肝炎病毒感染者中多次给药的安全性、耐受性、药代动力学特征和初步抗病毒活性的随机、双盲、安慰剂对照的I期临床研究
[Translation] A randomized, double-blind, placebo-controlled Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary antiviral activity of HH-006 injection after multiple doses in untreated chronic hepatitis B virus infected patients
NCT05275465
/ CompletedPhase 1
A Randomized, Placebo-controlled, Single-Ascending Dose Phase Ia Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
100 Clinical Results associated with HH-006
Login to view more data
100 Translational Medicine associated with HH-006
Login to view more data
100 Patents (Medical) associated with HH-006
Login to view more data
100 Deals associated with HH-006
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis B, ChronicPhase 1
China
Huahui Health Ltd.Huahui Health Ltd.
18 Dec 2024
Hepatitis DPhase 1
China
Huahui Health Ltd.Huahui Health Ltd.
30 Jan 2022
Hepatitis BDiscovery
Australia
Huahui Health Ltd.Huahui Health Ltd.
03 May 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free